This review highlights the diagnostic and prognostic utility of classic and emerging biomarkers for acute myocardial infarction in the elderly population.
May enhance AMI evaluation in elderly patients; leaves open prospective validation before practice change.
In the broadest context, biological markers, or biomarkers, are molecules that characterize a biological system or process. In the setting of cardiovascular disease, a number of biomarkers have become an integral part of diagnostic and risk stratification strategies. In this review, we will discuss classic and emerging biomarkers of cardiovascular disease and the role of these biomarkers in the diagnosis and prognosis of elderly patients presenting with acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Campbell et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: